Not approved (research only)ERR agonist (small molecule)Exercise-mimetic research
SLU-PP-332
SLU-PP-332 is a small-molecule estrogen-related receptor agonist studied in mice as an exercise mimetic; it is not a peptide.
What is SLU-PP-332?
SLU-PP-332 is a small-molecule estrogen-related receptor agonist studied in mice as an exercise mimetic; it is not a peptide. SLU-PP-332 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Key takeaways
- SLU-PP-332 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
- PubMed indexes 10 papers on SLU-PP-332 (0 tagged as clinical trials) as of October 19, 2026.
- 16 vendors in our directory listed SLU-PP-332 in their public catalog on October 19, 2026.
Structure
Regulatory & access status
SLU-PP-332 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on SLU-PP-332?
PubMed indexes 10 papers mentioning SLU-PP-332 in the title or abstract, 10 of them from the last five years and 0 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- A Synthetic ERR Agonist Alleviates Metabolic Syndrome. — J Pharmacol Exp Ther, 2024
- Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. — Circulation, 2024
- An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity. — J Pharmacol Exp Ther, 2026
- In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential. — Rapid Commun Mass Spectrom, 2026
- Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. — ACS Chem Biol, 2023
- Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling. — Int J Biol Macromol, 2026
What the evidence does not show
- Paper counts measure research attention, not whether SLU-PP-332 works or is safe.
- No clinical trial in humans is tagged in PubMed under this name.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Research suppliers that list SLU-PP-332
16 vendors in our directory listed a product matching SLU-PP-332 in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
- Atomik Labz
- Backroad Aminos
- BioGenix Peptides
- Bulk Peptide Supply
- Evolve BioPep
- Extreme Peptides
- Liberty Peptides
- Licensed Peptides
- Modern Aminos
- OmegAmino
- Pure Lab Peptides
- Royal Peptides
- San Diego Peptides
- Science.bio
- Southern Aminos
- Xcel Peptides
Prices per mg, where we could verify them, are on our price comparison.
SLU-PP-332 reconstitution math
Lab arithmetic only, not dosing guidance: vial-by-vial concentration tables are on SLU-PP-332 10 mg vial math.
SLU-PP-332 FAQ
Is SLU-PP-332 FDA-approved?
SLU-PP-332 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Is SLU-PP-332 safe?
There are no published human safety trials of SLU-PP-332 that we could find. Products sold as "research use only" have no FDA review of purity, sterility or dose, and are not for human use.
How much research is there on SLU-PP-332?
PubMed indexes 10 papers on SLU-PP-332 (0 tagged as clinical trials) as of October 19, 2026.
Who sells SLU-PP-332?
Atomik Labz, Backroad Aminos, BioGenix Peptides, Bulk Peptide Supply, Evolve BioPep, Extreme Peptides and 10 more listed it on their public catalogs when we checked; a listing is not an endorsement.
Related compounds
TRHMelanotan IPNC-27OvagenAOD-9604 + CJC-1295 + ipamorelin blendCardiogenLivagenCortagenAll bioregulators & other research compounds